Synthetic data only. Never enter patient information; nothing is sent or stored. For clinicians. Not FDA cleared.

CPE-008 · Context triggers

AI-11: Immune checkpoint inhibitor

Immune checkpoint inhibitor. Evaluates checkpoint inhibitor treatment.

Active rulePriority 2Adrenal engine v1.0.0

Condition

  • checkpoint inhibitor treatment
  • fatigue, headache, nausea, weakness, hyponatremia or hypotension

What it reports

  • Hypophysitis and primary adrenalitis are recognized immune-related adverse events: screen cortisol, ACTH, TSH, free T4 and sodium/potassium

Diagnostic boundary

  • Reporting and management belong to the treating oncology team.

Evidence

  • EV-ASCO-IRAE-2021Schneider BJ, Naidoo J, Santomasso BD, et al. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update. J Clin Oncol. 2021;39(36):4073-4126.Supports: Endocrine immune-related adverse events: hypophysitis and adrenal insufficiency

Cases where this rule fires

Open a case to see this rule fire with real inputs, then change the values until it stops.

The Clinical Intelligence Layer — transforming fragmented clinical information into structured intelligence for clinician review and action.

Contact Biod